New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

<div class="page" title="Page 4"><div class="section"><div class="layoutArea"><div class="column"><p><span>New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in p...

Full description

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-11-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:	http://www.rpcardio.ru/jour/article/view/332

id	doaj-4978440bb4e24f7ea92c0f2e77e98e0b
record_format	Article
spelling	doaj-4978440bb4e24f7ea92c0f2e77e98e0b2020-11-24T22:13:38ZengStolichnaya Izdatelskaya KompaniyaRacionalʹnaâ Farmakoterapiâ v Kardiologii1819-64462225-36532015-11-0111555155210.1234/1819-6446-2015-5-551-552332New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillationarticle Editorial<div class="page" title="Page 4"><div class="section"><div class="layoutArea"><div class="column"><p><span>New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation </span></p></div></div></div></div>http://www.rpcardio.ru/jour/article/view/332
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	article Editorial
spellingShingle	article Editorial New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation Racionalʹnaâ Farmakoterapiâ v Kardiologii
author_facet	article Editorial
author_sort	article Editorial
title	New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_short	New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_full	New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_fullStr	New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_full_unstemmed	New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
title_sort	new data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation
publisher	Stolichnaya Izdatelskaya Kompaniya
series	Racionalʹnaâ Farmakoterapiâ v Kardiologii
issn	1819-6446 2225-3653
publishDate	2015-11-01
description	<div class="page" title="Page 4"><div class="section"><div class="layoutArea"><div class="column"><p><span>New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation </span></p></div></div></div></div>
url	http://www.rpcardio.ru/jour/article/view/332
work_keys_str_mv	AT articleeditorial newdataoftherealclinicalpracticeconfirmslowincidenceofmajorbleedingwhenusingrivaroxabaninpatientswithnonvalvularatrialfibrillation
_version_	1725800435554451456

New data of the real clinical practice confirms low incidence of major bleeding when using rivaroxaban in patients with non-valvular atrial fibrillation

Similar Items